Financial statements Bbbiotech
Balance sheet data of BBBIOTECH
Year
|
2021
|
2022
|
2023
|
---|---|---|---|
Total assets | 1 541 262,07 | 1 965 685,34 | 1 159 198,05 |
A. Fixed assets | 1 457 999,68 | 1 584 608,24 | 123 685,00 |
B. Current assets | 83 262,39 | 381 077,10 | 1 035 513,05 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
Total liabilities | 1 541 262,07 | 1 965 685,34 | 1 159 198,05 |
A. Equity | 1 530 306,27 | 1 441 623,26 | 161 330,64 |
B. Liabilities and provisions for liabilities | 10 955,80 | 524 062,08 | 997 867,41 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | 3 755,80 | 516 862,08 | 984 367,41 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.